Narcos

MDA pharmaceutical now known as Juno Pharmaceuticals

We are focused on the sale of hospital generic and specialty pharmaceuticals.

We principally target injectable products for hospital use however aim to provide a robust portfolio of products including difficult to source or manufacture drugs, with niche market applications.

MDA is a member of the Juno group.

JunoLogonew500

Latest News

Name Change

  • March 6, 2020
  • MDA Inc.

MDA Pharmaceuticals is proud to announce we will now be known as Juno Pharmaceuticals.  MDA was founded in 2009 and has operated as a member of the Juno Pharmaceutical Group since 2011. Juno Pharmaceuticals continues to invest heavily in business development and is now emerging as a leading Canadian Supplier of generic products focuse...

Read more

Introducing Ertapenem for Injection

  • February 10, 2020
  • MDA Inc.

MDA is pleased to announce the launch of Ertapenem for Injection Product is now available in wholesalers ...

Read more

Introducing Carbetocin Pre-Filled Syringes

  • January 22, 2020
  • MDA Inc.

MDA is pleased to announce the launch of Carbetocin Pre-Filled Syringes Product is now available in wholesalers ...

Read more

Introducing Ipratropium/Salbutamol Ampoules

  • September 4, 2019
  • MDA Inc.

MDA is pleased to announce the launch of Ipratropium/Salbutamol Inhalation Solution Product is now available in wholesalers ...

Read more

Introducing Dexmedetomidine HCL for Injection

  • January 9, 2019
  • MDA Inc.

MDA is pleased to announce the launch of Dexmedetomidine HCL Product is now available in wholesalers   .                                              ...

Read more

Introducing Rocuronium Bromide for Injection

  • January 4, 2019
  • MDA Inc.

MDA is pleased to announce the launch of Rocuronium Bromide Product is now available in wholesalers                                 ...

Read more

Introducing Metoprolol Tartrate Injection

  • January 1, 2019
  • MDA Inc.

MDA is pleased to announce the launch of Metoprolol Tartrate Product is now available in wholesalers             ...

Read more

Introducing: Caspofungin Acetate for Injection

  • April 20, 2017
  • MDA Inc.

    MDA is pleased to announce the launch of Caspofungin Acetate for Injection Product is now available in wholesalers. ...

Read more

MDA Pharmaceuticals partners with the Canadian Pharmaceutical Distribution Network (CPDN)

  • March 16, 2017
  • MDA Inc.

Oakville, Ontario – March 16, 2017 – MDA Pharmaceuticals is proud to announce a new partnership with the Canadian Pharmaceutical Distribution Network (CPDN), a leading distribution channel for pharmaceutical products to Canadian hospitals. After initially established as a contract promoter, MDA partnered with the Juno Pharmace...

Read more

Our new office telephone number

  • July 26, 2016
  • MDA Inc.

Please note that effective July 1st, our head office contact number has changed to 1-905-829-3838. Customer service can still be reached at 1-888-882-8827. ...

Read more

Introducing: Ketorolac

  • July 20, 2016
  • MDA Inc.

MDA is pleased to announce the launch of Ketorolac. Product is now available in wholesalers. ...

Read more

Introducing: Sevoflurane

  • July 20, 2016
  • MDA Inc.

MDA is pleased to announce the launch of Sevoflurane, generic equivalent to SojournTM. Product is now available in wholesalers. ...

Read more

Introducing: Zoledronic

  • July 20, 2016
  • MDA Inc.

MDA is pleased to announce the launch of Zoledronic, generic equivalent to ZometaTM. Product is now available in wholesalers. ...

Read more